(2E)-3-(DiMethylaMino)-1-(pyridin-3-yl)prop-2-en-1-one;(2E)-3-(DiMethylaMino)-1-(3-pyridyl)prop-2-en-1-one (IMpurity of Nilotinib);(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one;(E)-3-(Dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one;Imatinib EP Impurity A (Nilotinib Impurity 16);Nilotinib Impurity 16 (Imatinib EP Impurity A);Imatinib impurity 14/(E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one;(E)-3-(dimethylamino)
(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one Usage And Synthesis
Uses
(2E)?-?3-?(Dimethylamino)?-?1-?(3-?pyridyl)?prop-?2-?en-?1-?one acts as a reagent for the synthesis of oxindole-linked indolyl-pyrimidine derivatives which are potential cytotoxic agents.
(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one Preparation Products And Raw materials